My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 118

    1.

    Immunostimulation and immunoinhibition of premalignant lesions.

    Prehn RT.

    Theor Biol Med Model. 2007 Feb 6;4:6.PMID: 17280618 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

    Muller AJ, Sharma MD, Chandler PR, Duhadaway JB, Everhart ME, Johnson BA 3rd, Kahler DJ, Pihkala J, Soler AP, Munn DH, Prendergast GC, Mellor AL.

    Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17073-8. Epub 2008 Oct 24.PMID: 18952840 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Immunologic surveillance at the marcoscopic level: nonselective elimination of premalignant skin papillomas.

    Lappé MA, Prehn RT.

    Cancer Res. 1969 Dec;29(12):2374-80. No abstract available. PMID: 5369684 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer.

    Young MR.

    J Immunother. 2008 Feb-Mar;31(2):148-56.PMID: 18481384 [PubMed - indexed for MEDLINE]Related articles

    5.

    Tumour specific transplantation antigens: possible origin in pre-malignant lesions.

    Lappé MA.

    Nature. 1969 Jul 5;223(5201):82-4. No abstract available. PMID: 5792439 [PubMed - indexed for MEDLINE]Related articles

    6.

    Does the immune reaction cause malignant transformation by disrupting cell-to-cell or cell-to-matrix communications?

    Prehn RT.

    Theor Biol Med Model. 2007 May 4;4:16. Review.PMID: 17480231 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors.

    Massi D, Marconi C, Franchi A, Bianchini F, Paglierani M, Ketabchi S, Miracco C, Santucci M, Calorini L.

    Hum Pathol. 2007 Oct;38(10):1516-25. Epub 2007 Jul 19.PMID: 17640716 [PubMed - indexed for MEDLINE]Related articles

    8.

    Development of carcinogen-induced skin tumors in mice with varied states of immune capacity.

    Outzen HC.

    Int J Cancer. 1980 Jul 15;26(1):87-92.PMID: 7239715 [PubMed - indexed for MEDLINE]Related articles

    9.

    Tumor-specific antigens of putatively nonviral tumors.

    Prehn RT.

    Cancer Res. 1968 Jul;28(7):1326-30. No abstract available. PMID: 5665985 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.

    López MN, Pereda C, Segal G, Muñoz L, Aguilera R, González FE, Escobar A, Ginesta A, Reyes D, González R, Mendoza-Naranjo A, Larrondo M, Compán A, Ferrada C, Salazar-Onfray F.

    J Clin Oncol. 2009 Feb 20;27(6):945-52. Epub 2009 Jan 12.PMID: 19139436 [PubMed - indexed for MEDLINE]Related articles

    11.

    Selective expression of inhibitory Fcgamma receptor by metastatic melanoma impairs tumor susceptibility to IgG-dependent cellular response.

    Cassard L, Cohen-Solal JF, Fournier EM, Camilleri-Broët S, Spatz A, Chouaïb S, Badoual C, Varin A, Fisson S, Duvillard P, Boix C, Loncar SM, Sastre-Garau X, Houghton AN, Avril MF, Gresser I, Fridman WH, Sautès-Fridman C.

    Int J Cancer. 2008 Dec 15;123(12):2832-9.PMID: 18798552 [PubMed - indexed for MEDLINE]Related articles

    12.

    Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.

    Kimpfler S, Sevko A, Ring S, Falk C, Osen W, Frank K, Kato M, Mahnke K, Schadendorf D, Umansky V.

    J Immunol. 2009 Nov 15;183(10):6330-7. Epub 2009 Oct 19.PMID: 19841169 [PubMed - indexed for MEDLINE]Related articles

    13.

    Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival.

    Nagorsen D, Voigt S, Berg E, Stein H, Thiel E, Loddenkemper C.

    J Transl Med. 2007 Nov 29;5:62.PMID: 18047662 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Tumor immune escape by the loss of homeostatic chemokine expression.

    Pivarcsi A, Müller A, Hippe A, Rieker J, van Lierop A, Steinhoff M, Seeliger S, Kubitza R, Pippirs U, Meller S, Gerber PA, Liersch R, Buenemann E, Sonkoly E, Wiesner U, Hoffmann TK, Schneider L, Piekorz R, Enderlein E, Reifenberger J, Rohr UP, Haas R, Boukamp P, Haase I, Nürnberg B, Ruzicka T, Zlotnik A, Homey B.

    Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19055-60. Epub 2007 Nov 19.PMID: 18025475 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Dendritic cells in the skin--potential use for melanoma treatment.

    El Marsafy S, Bagot M, Bensussan A, Mauviel A.

    Pigment Cell Melanoma Res. 2009 Feb;22(1):30-41. Epub 2008 Nov 27. Review.PMID: 19040502 [PubMed - indexed for MEDLINE]Related articles

    16.

    Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.

    Watanabe D, Goshima F, Mori I, Tamada Y, Matsumoto Y, Nishiyama Y.

    J Dermatol Sci. 2008 Jun;50(3):185-96. Epub 2008 Jan 15.PMID: 18226503 [PubMed - indexed for MEDLINE]Related articles

    17.

    Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies.

    O'Day SJ, Hamid O, Urba WJ.

    Cancer. 2007 Dec 15;110(12):2614-27. Review.PMID: 18000991 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Tumor-reactive CD4+ T cell responses to the melanoma-associated chondroitin sulphate proteoglycan in melanoma patients and healthy individuals in the absence of autoimmunity.

    Erfurt C, Sun Z, Haendle I, Schuler-Thurner B, Heirman C, Thielemans K, van der Bruggen P, Schuler G, Schultz ES.

    J Immunol. 2007 Jun 15;178(12):7703-9.PMID: 17548607 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Phase- and stage-related proportions of T cells bearing the transcription factor FOXP3 infiltrate primary melanoma.

    De Panfilis G, Campanini N, Santini M, Mori G, Tognetti E, Maestri R, Lombardi M, Froio E, Ferrari D, Ricci R.

    J Invest Dermatol. 2008 Mar;128(3):676-84. Epub 2007 Sep 13.PMID: 17851585 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Context-dependent roles of mutant B-Raf signaling in melanoma and colorectal carcinoma cell growth.

    Hao H, Muniz-Medina VM, Mehta H, Thomas NE, Khazak V, Der CJ, Shields JM.

    Mol Cancer Ther. 2007 Aug;6(8):2220-9.PMID: 17699719 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk